GNPX GENPREX INC Other Situations 8-K Filing 2023 - Annual Meeting and Clinical Trial Updates Genprex, Inc. held its 2023 Annual Meeting of Stockholders, electing directors and ratifying the appointment of an independent registered public accounting firm. They also provided updates on their clinical trials and the transition to a new manufacturing organization for their drug product.Get access to all SEC 8-K filings of the GENPREX INC